• Mashup Score: 1

    Gigamon analyzes the state of hybrid cloud security in 2023, investigating critical visibility gaps and unknown blind spots, CISO fears, deep observability and Zero Trust in its annual survey report: Hybrid Cloud Security: Perception vs. Reality.

    Tweet Tweets with this article
    • šŸŒ Dive into @gigamon's global survey on #hybridcloud security and explore Ian's insights on addressing blind spots. Learn more: https://t.co/A8oG7ijykv #HybridCloudSecurity #APAC https://t.co/7VX56IrOSO

  • Mashup Score: 2

    Your PrivacyASCO is committed to transparency regarding our websites and the ways we process data. When you visit our site, we may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences, your location, or your device and is mostly used to make the site work as you expect it to and to personalize your web experience with…

    Tweet Tweets with this article
    • Push for #ascobreakthrough! #ASCOBT2023 is a meeting bringing innovative medicines in #Oncology globally to #APAC #asia @lillian_siu @GlopesMd @ASCO @herbloong @jrgralow @CliffordHudis @ASCOPres https://t.co/WiqrU5xpNM

  • Mashup Score: 0

    Gigamon analyzes the state of hybrid cloud security in 2023, investigating critical visibility gaps and unknown blind spots, CISO fears, deep observability and Zero Trust in its annual survey report: Hybrid Cloud Security: Perception vs. Reality.

    Tweet Tweets with this article
    • Why are Australian organisations being breached, and how are Infosec teams responding? Get the latest insights and trends from @gigamon: https://t.co/BLfDKd3OHT #CloudSecurity #ThreatDetection #APAC #cybersecurity https://t.co/F7l3ekWdJs

  • Mashup Score: 0

    To foster education and collaboration between stakeholders of oncology drug development in Asia Pacific, improving patientsā€™ access to effective treatment.

    Tweet Tweets with this article
    • Our #AsiaPacificOncologyDrugDevelopmentConsortium (@apoddc) website is now live at https://t.co/PRuUKeeiED. As a collaborative group in #APAC region, we look forward to making #headways in various fronts of #oncology drug development internationally. @danieltanmd #ToshioShimizu https://t.co/o8pEA7xwu5